Pathological Circulating Factors in Moyamoya Disease
Open Access
- 8 February 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4) , 1696
Abstract
Moyamoya disease (MMD) is a cerebrovascular disease that presents with vascular stenosis and a hazy network of collateral formations in angiography. However, the detailed pathogenic pathway remains unknown. Studies have indicated that in addition to variations in the of genetic factor RNF213, unusual circulating angiogenetic factors observed in patients with MMD may play a critical role in producing “Moyamoya vessels”. Circulating angiogenetic factors, such as growth factors, vascular progenitor cells, cytokines, inflammatory factors, and other circulating proteins, could promote intimal hyperplasia in vessels and excessive collateral formation with defect structures through endothelial hyperplasia, smooth muscle migration, and atypical neovascularization. This study summarizes the hypothesized pathophysiology of how these circulating factors affect MMD and the interactive modulation between them.Keywords
Funding Information
- Taipei Medical University (108TMU-SHH-12)
This publication has 51 references indexed in Scilit:
- The Role of VEGF and KDR Polymorphisms in Moyamoya Disease and Collateral RevascularizationPLOS ONE, 2012
- Clinical and Immunopathological Features of Moyamoya DiseasePLOS ONE, 2012
- Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular DevelopmentPLOS ONE, 2011
- Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic DiseaseThe American Journal of Human Genetics, 2009
- Increased Levels of Circulating Endothelial Progenitor Cells in Patients With Moyamoya DiseaseStroke, 2009
- The ubiquitin-interacting motif of 26S proteasome subunit S5a induces A549 lung cancer cell deathBiochemical and Biophysical Research Communications, 2007
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- Elevation of CRABP-I in the Cerebrospinal Fluid of Patients With Moyamoya DiseaseStroke, 2003
- Angiogenic Factors in Moyamoya DiseaseStroke, 1996